Piramal Pharma Limited (PPLPHARMA.NS) NSE

192.64

-1.52(-0.78%)

Updated at October 17 03:30PM

Currency In INR

Valuation

Market Cap302.24B
Enterprise Value345.79B
P/E Ratio258.85
PEG Ratio35.72
Price/Sales Ratio2.79
Price/Book Ratio3.12
Enterprise/Revenue2.79
Enterprise/EBITDA17.16

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.38

Management Effectiveness

Return On Assets0
Return On Equity0.01

Income Statement

Revenue91.51B
Revenue/Share69.31
Gross Profit59.2B
EBITDA14.04B
Net Income911.3M
Diluted EPS0.68

Balance Sheet

Total Cash4.09B
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share61.66

Price History

52-Week Change-15.55
52-Week High307.9
52-Week Low181.73
Moving Average 50 Days195.38
Moving Average 200 Days206.97

Statistics

Average Volume3.88M
Shares Outstanding1.32B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.14
Trailing Annual Dividend Yield0.07
Payout Ratio0
Last Split Factor1023:1000
Last Split DateAugust 02, 2023